Christiana Care Health System, Newark, DE, USA.
CERENOVUS, Johnson & Johnson, Irvine, CA, USA.
Interv Neuroradiol. 2023 Aug;29(4):434-441. doi: 10.1177/15910199221089766. Epub 2022 Apr 21.
In US hospitals, the liquid embolic systems (LESs) n-butyl cyanoacrylate (n-BCA) and ethylene vinyl alcohol copolymer (EVOH) are used for brain arteriovenous malformation (bAVM) embolization to achieve presurgical devascularization. The aim of this study was to perform an economic analysis comparing four techniques for bAVM embolization based on LES, ancillary device, and angiography suite time costs.
An economic model was developed comparing the embolization costs for n-BCA, EVOH with the plug and push technique, EVOH with detachable-tip microcatheters, and EVOH with balloon microcatheters. Per procedure costs were calculated for bAVMs with one to four pedicles. Annual cohort analyses were performed to evaluate the potential impact for low and high-volume centers. Sensitivity analyses were performed to determine cost drivers.
The analyses showed that the n-BCA technique was the least costly of the four techniques. Total per procedure costs for one to four embolized pedicles ranged from $5941 to $10,074 for the n-BCA technique, $8428 to $30,345 for the EVOH balloon microcatheter technique, $12,711 to $47,477 for the EVOH plug and push technique, and $13,900 to $52,233 for the EVOH detachable-tip microcatheter technique. Cohort analyses costs for 52 annual cases ranged from $308,953 to $523,838 with the n-BCA technique and from $722,816 to $2,716,096 with the EVOH detachable-tip microcatheter technique.
Procedure costs associated with n-BCA are lower than those with each of the three EVOH techniques examined. Future cost analyses should compare the costs of new LES products once available.
在美国的医院中,液体栓塞系统(LES)正丁基氰基丙烯酸酯(n-BCA)和乙烯-乙烯醇共聚物(EVOH)被用于脑动静脉畸形(bAVM)栓塞以实现术前血管化。本研究旨在进行一项经济分析,比较基于 LES、辅助装置和血管造影套件时间成本的四种 bAVM 栓塞技术。
开发了一种经济模型,比较了 n-BCA、EVOH 与塞子和推注技术、EVOH 与可解脱尖端微导管以及 EVOH 与球囊微导管的栓塞成本。对于具有一个至四个分支的 bAVM,计算了每个程序的成本。进行了年度队列分析,以评估低容量和高容量中心的潜在影响。进行了敏感性分析以确定成本驱动因素。
分析表明,n-BCA 技术是四种技术中成本最低的。n-BCA 技术的一个至四个栓塞分支的每个程序总费用范围为 5941 美元至 10074 美元,EVOH 球囊微导管技术为 8428 美元至 30345 美元,EVOH 塞子和推注技术为 12711 美元至 47477 美元,EVOH 可解脱尖端微导管技术为 13900 美元至 52233 美元。52 例年度病例的队列分析成本范围为 n-BCA 技术为 308953 美元至 523838 美元,EVOH 可解脱尖端微导管技术为 722816 美元至 2716096 美元。
与 EVOH 的三种技术相比,n-BCA 相关程序的成本较低。未来的成本分析应在新的 LES 产品上市后比较其成本。